Science And The Presidency: 1993

Each four-year presidential election cycle frames an era of United States politics, including science in high politics. The greenhouse effect, the Valdez oil spill, and biodiversity; AIDS, tuberculosis, and other emerging diseases; fetal tissue research, genome mapping, DNA patents, and DNA fingerprinting; chemical weapons and unemployed Soviet bomb scientists; the space station and the supercollider: The past term has been a busy one for science in the White House. The next term will be b

Written byJoshua Lederberg
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The greenhouse effect, the Valdez oil spill, and biodiversity; AIDS, tuberculosis, and other emerging diseases; fetal tissue research, genome mapping, DNA patents, and DNA fingerprinting; chemical weapons and unemployed Soviet bomb scientists; the space station and the supercollider: The past term has been a busy one for science in the White House.

The next term will be busy, too. Outstanding challenges include stopping the proliferation of high-tech weapons, rationalizing medical care systems, building a civilian technology agency, and effecting widespread improvements in secondary school education in math and science. Scientists will be particularly concerned about an informed sensitivity to the consequences of budget restrictions on investigator-initiated ("small") science.

Can the accomplishments and lessons of the past presidential term help set goals for the next?

The incumbent administration has given high priority to improving the processes of governmental decision-making about science, with notable and, it is hoped, durable accomplishments, among them:

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies